Table 4.
Partial correlation analysis between AQP4/CX43/CX30 and sleep quality.
| Terms | AQP4 (pg/mL) | CX43 (pg/mL) | CX30 (pg/mL) |
|---|---|---|---|
| PSQI | 0.046 | −0.095 | −0.101 |
| TST | −0.053 | −0.114 | −0.085 |
| SOL | −0.103 | −0.003 | −0.146 |
| SE | −0.028 | −0.077 | −0.062 |
| N1 | −0.132 | −0.206 | −0.137 |
| N1% | −0.095 | −0.187 | −0.132 |
| N3 | 0.250* | 0.323** | 0.334** |
| N3% | 0.233* | 0.302* | 0.335** |
| REM | −0.017 | 0.068 | 0.095 |
| REM% | −0.024 | 0.062 | 0.098 |
| AHI | −0.075 | −0.204 | −0.128 |
| ODI | −0.049 | −0.178 | −0.097 |
| TS90 | −0.036 | −0.158 | −0.074 |
Controlling for age, sex, education, HAMD, and HAMA.
*
P < 0.05 and
**
P < 0.01.
AHI, apnea hypopnea index; AQP4, aquaporin-4; CX30, connexin 30; CX43, connexin 43; N1, sleep stage 1; N1%, percentage of the sleep stage 1; N3, sleep stage 3; N3%, percentage of the sleep stage 3; ODI, oxygen desaturation index; PSQI, Pittsburgh Sleep Quality Index; REM, rapid eye movement sleep time; REM%, percentage of the rapid eye movement sleep time SE, sleep efficiency; SOL, sleep onset latency; TST, total sleep time. TS90, SpO2 time <90%.